(Date:11/19/2009)...EAL, Nov. 19 /PRNewswire/ - Aegera Therapeutics In... in a randomized Phase 2B study of AEG35156, a tar...nt for multiple oncology indications. ,, The st...udy of the X-Linked Inhibitor of Apoptosis (XIAP) ...dose Cytarabine and Idarubicin in AML Following Fa...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies For...o Coordinate Best Practices in Risk Reduction ,F...wide Gene Synthesis Capacity , ...ld’s leading gene synthesis companies today ...screening protocol to promote biosecurity in the g...
(Date:11/19/2009)... VIENNA, Austria, November 19 AF...m on one product candidate at an unexpectedly earl... is planned to enter into,Phase II clinical trial ...ately follows the completion of two Phase I trials...sed its fast decision on the first interim,analysi...
(Date:11/18/2009)...he National Institute of Standards and Technology ...ensive method for detecting and measuring elusive ...nvisible spoilage in food or pesticides distribute...s more sensitive than conventional techniques for ...arlike water molecules, having distinct electrical...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2... can be difficult for paleontologists to determine...h as clams, represent different species. After all...isms dead for millions of years, so who knows if t...here that was not possible.......A study by Virgin...
Today, even the best cancer treatments kill about as many healthy cells as they do cancer cells but John-Stephen A. Taylor, Ph.D., professor of chemistry at Washington University in St. Louis, has a p
...a pivotal role in controlling genes in yeast acts ...usly thought to be the case, according to a new st...Its mode of action is also distinct from that of o... it falls, the scientists found. Because the human...
...s of Health and an international consortium of res..., Nigeria, and the United States will announce a p... map of the human genome. The International HapMa...ps researchers more rapidly discover genes contrib...
Impact of geography on species challenges paleontologists 2Tailor-made cancer drugs: Wave of the future? 2Tailor-made cancer drugs: Wave of the future? 3'Ping-Pong' mechanism seen in gene-controlling enzyme 2... copies of any one of about 12 genes that make the...op FA, which is characterized by increased inciden...things. However, individuals with just a single mu...sed risk of developing cancer. This occurs when th...
...nch of the Human Genome Project, which released a ...any researchers have dedicated themselves to creat...enetic sequence "maps" available for study. Scient...l Rhesus Macaque Sequence and Analysis Consortium,...
...hicago have found an unsuspected link between the ...terol and triglycerides in the blood) in mice. The... of heart disease by lowering elevated lipid level...he research teamled by James C. Lo, an MD, PhD stu...
A new technology developed at the University of Toronto is revealing biochemical processes responsible for diseases such as cystic fibrosis and could one day pave the way for pharmaceutical applicatio
LSU professors monkey around with the Rhesus Macaque genome 2LSU professors monkey around with the Rhesus Macaque genome 3Link found between immune system and high plasma lipid levels 2Technology reveals 'lock and key' proteins behind diseases 2